EMA Holds Meeting on 3Rs in the Testing of Medicines

The EMA has established an ad-hoc expert group on the application of the '3Rs' - replacement, reduction and refinement of animal testing - in the development of medicines.

The European Medicines Agency has established an ad-hoc expert group on the application of the '3Rs' - replacement, reduction and refinement of animal testing - in the development of medicines.

The group, whose first meeting started last week, would give advice and recommendations to the Agency's Committee for Medicinal Products for Human Use (CHMP) and Committee for Medicinal Products for Veterinary Use (CVMP) on the use of animals and the application of the 3Rs in the testing of human and veterinary medicines.

The Agency established the expert group in order to foster the implementation of the 3Rs agenda in the testing of medicines for regulatory purposes and to allow the Agency and its network of regulatory and scientific experts to contribute to developments i